Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas — Clinical Trial Site

10 Registered trials

5 Currently recruiting

Organisation

Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas

Location

Liptovsky Mikulas, Slovakia

Identifier

ORG-100048223

Address

Palucanska 25, Paludzka, 031 01, Slovakia

Departments

Department of Phychiatry
neurologická ambulancia
Neurologická ambulancia Palúčanská 214/25 03101 Liptovský Mikuláš
Neurologicke oddelenie
Psychiatric
Psychiatricke oddelenie

Clinical trials at this site (10)

Search interface

An Open-label Study of Azetukalner in Major Depressive Disorder Recruiting

2025-523618-10-00 Major Depressive Disorder 5 2026-06-04
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder Recruiting

2025-523202-32-00 Major Depressive Disorder 5 2026-02-26
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Chronic migraine 5 2025-10-06
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Episodic migraine 5 2025-10-06
A study to measure how well seltorexant works in adult depressed patients and how safe it is both for short- and long-term use when taken wi… Recruiting

2023-509070-36-00 Major Depressive Disorder with Insomnia Symptoms 5 2025-03-18
Randomized, Double-Blind, Placebo-Controlled, Multiple-Attack Study with an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerabil… Ended

2023-506029-12-00 Migraine 5 2024-04-03
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 Migraine 4 2024-08-14
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. Ended

2024-512646-42-00 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP 4 2023-06-27
A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended

2023-508163-74-00 Major Depressive Disorder 5 2023-06-12
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18